1. Home
  2. Labeler Index
  3. Bryant Ranch Prepack
  4. 71335-1975
  5. Product Images: Desvenlafaxine

Product Images Desvenlafaxine

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. chemical structure - des structure
  2. figure 1 - figure 1
  3. figure 2 - figure 2
  4. figure 3 - figure 3
  5. figure 4 - figure 4
  6. figure 5 - figure 5
  7. Label - lbl713351975

Product Label Images

The following 7 images provide visual information about the product associated with Desvenlafaxine NDC 71335-1975 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure - des structure

chemical structure - des structure

figure 1 - figure 1

figure 1 - figure 1

The text describes the geometric mean ratios for maximum concentration and area under the curve for drugs in patients with varying degrees of renal and hepatic impairment, as well as in different populations based on gender and age. These ratios are expressed with 90% confidence intervals. The text also explains that ESRD stands for End Stage Renal Disease.*

figure 2 - figure 2

figure 2 - figure 2

This appears to be data from a clinical trial measuring the effect of CYP3A4 inhibitors on the drug ketoconazole. The data shows the geometric mean ratio (90% confidence interval) of the maximum concentration (Cmax) of ketoconazole in the presence of the inhibitors compared to a reference (presumably without inhibitors). The table displays two time points, with the second time point resulting in a 43% increase in ketoconazole Cmax.*

figure 3 - figure 3

figure 3 - figure 3

This is a table displaying the results of a pharmacokinetic study on Desvenlafaxine, a drug that is a substrate for both CYP2D6 and CYP3A4 enzymes. The table shows the geometric mean ratios (90% CI) for Desvenlafaxine's effects on the maximum concentration (Cmax) and area under the curve (AUC) of other drugs, such as Desipramine, Midazolam, Tamoxifen, and Aripiprazole. The table also displays the change relative to reference values for each drug.*

figure 4 - figure 4

figure 4 - figure 4

The given text describes a graph that shows the estimated proportion of patients with relapse over time after taking Desvenlafaxine Extended-Release Tablets 50 mg or Placebo. The horizontal axis shows the time to relapse measured in days from randomization, and the vertical axis shows the estimated proportion of patients with relapse in percentage. However, the graph is not fully visible as some parts are missing.*

figure 5 - figure 5

figure 5 - figure 5

Label - lbl713351975

Label - lbl713351975

This appears to be a medication packaging label. The medication is a 25mg tablet of a drug called "Pristiq", which is packaged by a company called "Bryant Ranck Prepack". The label includes information about the manufacturer ("Yichang Humanwell OSD Plant"), the expiration date, NDC number, and storage instructions. It also includes a warning to keep the medication out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.